Rare reports of clotting events have occurred in some people taking GLP-1 drugs, but health experts havent confirmed that the medications themselves caused the clots
Given their non-invasive nature, accessibility, and cost-effectiveness of sublingual formulations, they may represent a promising approach for long-term B12 management, particularly in patients with impaired absorption or in resource-limited settings
Patients should pause further dose increases until symptoms have settled and discussed with their healthcare team
Epigenetics and trained immunity
NovoNordisk the company that make ozempic are currently trying to have a 2mg dose approved for people with type 2 diabetes and this is currently under consideration by the FDA
These readings will provide invaluable data to you and your healthcare team , helping you adjust your Ozempic dosage accordingly